nodes	percent_of_prediction	percent_of_DWPC	metapath
Dasatinib—CYP3A5—Disulfiram—alcohol dependence	0.0796	0.297	CbGbCtD
Dasatinib—ABCB1—Naltrexone—alcohol dependence	0.0557	0.208	CbGbCtD
Dasatinib—CYP1A2—Citalopram—alcohol dependence	0.0422	0.158	CbGbCtD
Dasatinib—ABCB1—Citalopram—alcohol dependence	0.0369	0.138	CbGbCtD
Dasatinib—CYP3A4—Disulfiram—alcohol dependence	0.031	0.116	CbGbCtD
Dasatinib—CYP3A4—Citalopram—alcohol dependence	0.0221	0.0826	CbGbCtD
Dasatinib—Haemoglobin—Acamprosate—alcohol dependence	0.000682	0.00236	CcSEcCtD
Dasatinib—Haemorrhage—Acamprosate—alcohol dependence	0.000679	0.00235	CcSEcCtD
Dasatinib—Hepatitis—Acamprosate—alcohol dependence	0.000679	0.00235	CcSEcCtD
Dasatinib—Hepatobiliary disease—Naltrexone—alcohol dependence	0.000676	0.00234	CcSEcCtD
Dasatinib—Epistaxis—Naltrexone—alcohol dependence	0.000675	0.00233	CcSEcCtD
Dasatinib—Oedema peripheral—Acamprosate—alcohol dependence	0.000668	0.00231	CcSEcCtD
Dasatinib—Eczema—Citalopram—alcohol dependence	0.000654	0.00226	CcSEcCtD
Dasatinib—Visual impairment—Acamprosate—alcohol dependence	0.000654	0.00226	CcSEcCtD
Dasatinib—Dizziness—Disulfiram—alcohol dependence	0.000647	0.00224	CcSEcCtD
Dasatinib—Hepatitis—Naltrexone—alcohol dependence	0.000642	0.00222	CcSEcCtD
Dasatinib—Libido decreased—Citalopram—alcohol dependence	0.000634	0.00219	CcSEcCtD
Dasatinib—Tinnitus—Acamprosate—alcohol dependence	0.000633	0.00219	CcSEcCtD
Dasatinib—Connective tissue disorder—Naltrexone—alcohol dependence	0.000631	0.00218	CcSEcCtD
Dasatinib—Amnesia—Citalopram—alcohol dependence	0.000626	0.00217	CcSEcCtD
Dasatinib—Visual disturbance—Citalopram—alcohol dependence	0.000621	0.00215	CcSEcCtD
Dasatinib—Atrial fibrillation—Citalopram—alcohol dependence	0.000621	0.00215	CcSEcCtD
Dasatinib—Rash—Disulfiram—alcohol dependence	0.000617	0.00213	CcSEcCtD
Dasatinib—Headache—Disulfiram—alcohol dependence	0.000613	0.00212	CcSEcCtD
Dasatinib—Immune system disorder—Acamprosate—alcohol dependence	0.000613	0.00212	CcSEcCtD
Dasatinib—Chills—Acamprosate—alcohol dependence	0.000609	0.00211	CcSEcCtD
Dasatinib—Cardiac failure—Citalopram—alcohol dependence	0.000603	0.00208	CcSEcCtD
Dasatinib—Cerebrovascular accident—Citalopram—alcohol dependence	0.0006	0.00208	CcSEcCtD
Dasatinib—Eye disorder—Naltrexone—alcohol dependence	0.0006	0.00208	CcSEcCtD
Dasatinib—Alopecia—Acamprosate—alcohol dependence	0.0006	0.00207	CcSEcCtD
Dasatinib—Tinnitus—Naltrexone—alcohol dependence	0.000599	0.00207	CcSEcCtD
Dasatinib—Cardiac disorder—Naltrexone—alcohol dependence	0.000596	0.00206	CcSEcCtD
Dasatinib—Mental disorder—Acamprosate—alcohol dependence	0.000595	0.00206	CcSEcCtD
Dasatinib—Malnutrition—Acamprosate—alcohol dependence	0.000591	0.00204	CcSEcCtD
Dasatinib—Gastrointestinal haemorrhage—Citalopram—alcohol dependence	0.000588	0.00203	CcSEcCtD
Dasatinib—Disturbance in sexual arousal—Citalopram—alcohol dependence	0.000583	0.00202	CcSEcCtD
Dasatinib—Angiopathy—Naltrexone—alcohol dependence	0.000583	0.00202	CcSEcCtD
Dasatinib—Immune system disorder—Naltrexone—alcohol dependence	0.00058	0.00201	CcSEcCtD
Dasatinib—Affect lability—Citalopram—alcohol dependence	0.000579	0.002	CcSEcCtD
Dasatinib—Mediastinal disorder—Naltrexone—alcohol dependence	0.000579	0.002	CcSEcCtD
Dasatinib—Dysgeusia—Acamprosate—alcohol dependence	0.000578	0.002	CcSEcCtD
Dasatinib—Chills—Naltrexone—alcohol dependence	0.000576	0.00199	CcSEcCtD
Dasatinib—Muscle spasms—Acamprosate—alcohol dependence	0.000568	0.00196	CcSEcCtD
Dasatinib—Face oedema—Citalopram—alcohol dependence	0.000568	0.00196	CcSEcCtD
Dasatinib—Alopecia—Naltrexone—alcohol dependence	0.000567	0.00196	CcSEcCtD
Dasatinib—Mental disorder—Naltrexone—alcohol dependence	0.000562	0.00195	CcSEcCtD
Dasatinib—Malnutrition—Naltrexone—alcohol dependence	0.000559	0.00193	CcSEcCtD
Dasatinib—Tremor—Acamprosate—alcohol dependence	0.000553	0.00191	CcSEcCtD
Dasatinib—Ill-defined disorder—Acamprosate—alcohol dependence	0.000548	0.0019	CcSEcCtD
Dasatinib—Dysgeusia—Naltrexone—alcohol dependence	0.000547	0.00189	CcSEcCtD
Dasatinib—Anaemia—Acamprosate—alcohol dependence	0.000546	0.00189	CcSEcCtD
Dasatinib—Dry skin—Citalopram—alcohol dependence	0.000539	0.00186	CcSEcCtD
Dasatinib—Muscle spasms—Naltrexone—alcohol dependence	0.000537	0.00186	CcSEcCtD
Dasatinib—Hypokalaemia—Citalopram—alcohol dependence	0.000535	0.00185	CcSEcCtD
Dasatinib—Malaise—Acamprosate—alcohol dependence	0.000533	0.00184	CcSEcCtD
Dasatinib—Breast disorder—Citalopram—alcohol dependence	0.000531	0.00184	CcSEcCtD
Dasatinib—Vertigo—Acamprosate—alcohol dependence	0.000531	0.00184	CcSEcCtD
Dasatinib—Syncope—Acamprosate—alcohol dependence	0.00053	0.00183	CcSEcCtD
Dasatinib—Aspartate aminotransferase increased—Citalopram—alcohol dependence	0.00053	0.00183	CcSEcCtD
Dasatinib—Vision blurred—Naltrexone—alcohol dependence	0.000527	0.00182	CcSEcCtD
Dasatinib—Tremor—Naltrexone—alcohol dependence	0.000524	0.00181	CcSEcCtD
Dasatinib—Palpitations—Acamprosate—alcohol dependence	0.000522	0.00181	CcSEcCtD
Dasatinib—Gastritis—Citalopram—alcohol dependence	0.00052	0.0018	CcSEcCtD
Dasatinib—Loss of consciousness—Acamprosate—alcohol dependence	0.000519	0.0018	CcSEcCtD
Dasatinib—Muscular weakness—Citalopram—alcohol dependence	0.000519	0.00179	CcSEcCtD
Dasatinib—Alanine aminotransferase increased—Citalopram—alcohol dependence	0.000519	0.00179	CcSEcCtD
Dasatinib—Ill-defined disorder—Naltrexone—alcohol dependence	0.000519	0.00179	CcSEcCtD
Dasatinib—Cough—Acamprosate—alcohol dependence	0.000515	0.00178	CcSEcCtD
Dasatinib—Convulsion—Acamprosate—alcohol dependence	0.000512	0.00177	CcSEcCtD
Dasatinib—Abdominal distension—Citalopram—alcohol dependence	0.000512	0.00177	CcSEcCtD
Dasatinib—Hypertension—Acamprosate—alcohol dependence	0.00051	0.00176	CcSEcCtD
Dasatinib—Asthma—Citalopram—alcohol dependence	0.000508	0.00176	CcSEcCtD
Dasatinib—Dysphagia—Citalopram—alcohol dependence	0.000508	0.00176	CcSEcCtD
Dasatinib—Malaise—Naltrexone—alcohol dependence	0.000504	0.00174	CcSEcCtD
Dasatinib—Arthralgia—Acamprosate—alcohol dependence	0.000503	0.00174	CcSEcCtD
Dasatinib—Myalgia—Acamprosate—alcohol dependence	0.000503	0.00174	CcSEcCtD
Dasatinib—Chest pain—Acamprosate—alcohol dependence	0.000503	0.00174	CcSEcCtD
Dasatinib—Syncope—Naltrexone—alcohol dependence	0.000501	0.00173	CcSEcCtD
Dasatinib—Anxiety—Acamprosate—alcohol dependence	0.000501	0.00173	CcSEcCtD
Dasatinib—Bronchospasm—Citalopram—alcohol dependence	0.0005	0.00173	CcSEcCtD
Dasatinib—Unspecified disorder of skin and subcutaneous tissue—Acamprosate—alcohol dependence	0.000499	0.00173	CcSEcCtD
Dasatinib—Pancreatitis—Citalopram—alcohol dependence	0.000498	0.00172	CcSEcCtD
Dasatinib—Discomfort—Acamprosate—alcohol dependence	0.000497	0.00172	CcSEcCtD
Dasatinib—Angina pectoris—Citalopram—alcohol dependence	0.000495	0.00171	CcSEcCtD
Dasatinib—Palpitations—Naltrexone—alcohol dependence	0.000494	0.00171	CcSEcCtD
Dasatinib—Loss of consciousness—Naltrexone—alcohol dependence	0.000491	0.0017	CcSEcCtD
Dasatinib—Cough—Naltrexone—alcohol dependence	0.000488	0.00169	CcSEcCtD
Dasatinib—Confusional state—Acamprosate—alcohol dependence	0.000486	0.00168	CcSEcCtD
Dasatinib—Convulsion—Naltrexone—alcohol dependence	0.000484	0.00168	CcSEcCtD
Dasatinib—Pancytopenia—Citalopram—alcohol dependence	0.000483	0.00167	CcSEcCtD
Dasatinib—Hypertension—Naltrexone—alcohol dependence	0.000483	0.00167	CcSEcCtD
Dasatinib—Infection—Acamprosate—alcohol dependence	0.000479	0.00166	CcSEcCtD
Dasatinib—Arthralgia—Naltrexone—alcohol dependence	0.000476	0.00165	CcSEcCtD
Dasatinib—Chest pain—Naltrexone—alcohol dependence	0.000476	0.00165	CcSEcCtD
Dasatinib—Myalgia—Naltrexone—alcohol dependence	0.000476	0.00165	CcSEcCtD
Dasatinib—Shock—Acamprosate—alcohol dependence	0.000474	0.00164	CcSEcCtD
Dasatinib—Anxiety—Naltrexone—alcohol dependence	0.000474	0.00164	CcSEcCtD
Dasatinib—Unspecified disorder of skin and subcutaneous tissue—Naltrexone—alcohol dependence	0.000473	0.00163	CcSEcCtD
Dasatinib—Upper respiratory tract infection—Citalopram—alcohol dependence	0.000472	0.00163	CcSEcCtD
Dasatinib—Thrombocytopenia—Acamprosate—alcohol dependence	0.000472	0.00163	CcSEcCtD
Dasatinib—Tachycardia—Acamprosate—alcohol dependence	0.000471	0.00163	CcSEcCtD
Dasatinib—Discomfort—Naltrexone—alcohol dependence	0.00047	0.00163	CcSEcCtD
Dasatinib—Pollakiuria—Citalopram—alcohol dependence	0.00047	0.00162	CcSEcCtD
Dasatinib—Skin disorder—Acamprosate—alcohol dependence	0.000468	0.00162	CcSEcCtD
Dasatinib—Hyperhidrosis—Acamprosate—alcohol dependence	0.000466	0.00161	CcSEcCtD
Dasatinib—Photosensitivity reaction—Citalopram—alcohol dependence	0.000464	0.0016	CcSEcCtD
Dasatinib—Weight increased—Citalopram—alcohol dependence	0.000463	0.0016	CcSEcCtD
Dasatinib—Confusional state—Naltrexone—alcohol dependence	0.00046	0.00159	CcSEcCtD
Dasatinib—Weight decreased—Citalopram—alcohol dependence	0.00046	0.00159	CcSEcCtD
Dasatinib—Anorexia—Acamprosate—alcohol dependence	0.00046	0.00159	CcSEcCtD
Dasatinib—Oedema—Naltrexone—alcohol dependence	0.000456	0.00158	CcSEcCtD
Dasatinib—Pneumonia—Citalopram—alcohol dependence	0.000456	0.00158	CcSEcCtD
Dasatinib—Infection—Naltrexone—alcohol dependence	0.000453	0.00157	CcSEcCtD
Dasatinib—Infestation NOS—Citalopram—alcohol dependence	0.000453	0.00157	CcSEcCtD
Dasatinib—Infestation—Citalopram—alcohol dependence	0.000453	0.00157	CcSEcCtD
Dasatinib—Hypotension—Acamprosate—alcohol dependence	0.000451	0.00156	CcSEcCtD
Dasatinib—Shock—Naltrexone—alcohol dependence	0.000449	0.00155	CcSEcCtD
Dasatinib—Nervous system disorder—Naltrexone—alcohol dependence	0.000447	0.00155	CcSEcCtD
Dasatinib—Acute coronary syndrome—Citalopram—alcohol dependence	0.000447	0.00155	CcSEcCtD
Dasatinib—Tachycardia—Naltrexone—alcohol dependence	0.000445	0.00154	CcSEcCtD
Dasatinib—Myocardial infarction—Citalopram—alcohol dependence	0.000444	0.00154	CcSEcCtD
Dasatinib—Neuropathy peripheral—Citalopram—alcohol dependence	0.000444	0.00154	CcSEcCtD
Dasatinib—Skin disorder—Naltrexone—alcohol dependence	0.000443	0.00153	CcSEcCtD
Dasatinib—Stomatitis—Citalopram—alcohol dependence	0.000442	0.00153	CcSEcCtD
Dasatinib—Hyperhidrosis—Naltrexone—alcohol dependence	0.000441	0.00153	CcSEcCtD
Dasatinib—Conjunctivitis—Citalopram—alcohol dependence	0.00044	0.00152	CcSEcCtD
Dasatinib—Musculoskeletal discomfort—Acamprosate—alcohol dependence	0.000439	0.00152	CcSEcCtD
Dasatinib—Insomnia—Acamprosate—alcohol dependence	0.000436	0.00151	CcSEcCtD
Dasatinib—Anorexia—Naltrexone—alcohol dependence	0.000435	0.0015	CcSEcCtD
Dasatinib—Haematuria—Citalopram—alcohol dependence	0.000432	0.00149	CcSEcCtD
Dasatinib—Dyspnoea—Acamprosate—alcohol dependence	0.00043	0.00149	CcSEcCtD
Dasatinib—Somnolence—Acamprosate—alcohol dependence	0.000429	0.00148	CcSEcCtD
Dasatinib—Hepatobiliary disease—Citalopram—alcohol dependence	0.000429	0.00148	CcSEcCtD
Dasatinib—Epistaxis—Citalopram—alcohol dependence	0.000427	0.00148	CcSEcCtD
Dasatinib—Dyspepsia—Acamprosate—alcohol dependence	0.000424	0.00147	CcSEcCtD
Dasatinib—Decreased appetite—Acamprosate—alcohol dependence	0.000419	0.00145	CcSEcCtD
Dasatinib—Gastrointestinal disorder—Acamprosate—alcohol dependence	0.000416	0.00144	CcSEcCtD
Dasatinib—Musculoskeletal discomfort—Naltrexone—alcohol dependence	0.000416	0.00144	CcSEcCtD
Dasatinib—Insomnia—Naltrexone—alcohol dependence	0.000413	0.00143	CcSEcCtD
Dasatinib—Pain—Acamprosate—alcohol dependence	0.000412	0.00143	CcSEcCtD
Dasatinib—Constipation—Acamprosate—alcohol dependence	0.000412	0.00143	CcSEcCtD
Dasatinib—Haemoglobin—Citalopram—alcohol dependence	0.000409	0.00141	CcSEcCtD
Dasatinib—Haemorrhage—Citalopram—alcohol dependence	0.000407	0.00141	CcSEcCtD
Dasatinib—Hepatitis—Citalopram—alcohol dependence	0.000407	0.00141	CcSEcCtD
Dasatinib—Dyspnoea—Naltrexone—alcohol dependence	0.000407	0.00141	CcSEcCtD
Dasatinib—Somnolence—Naltrexone—alcohol dependence	0.000406	0.0014	CcSEcCtD
Dasatinib—Urinary tract disorder—Citalopram—alcohol dependence	0.000402	0.00139	CcSEcCtD
Dasatinib—Oedema peripheral—Citalopram—alcohol dependence	0.000401	0.00139	CcSEcCtD
Dasatinib—Connective tissue disorder—Citalopram—alcohol dependence	0.0004	0.00138	CcSEcCtD
Dasatinib—Urethral disorder—Citalopram—alcohol dependence	0.000399	0.00138	CcSEcCtD
Dasatinib—Feeling abnormal—Acamprosate—alcohol dependence	0.000397	0.00137	CcSEcCtD
Dasatinib—Decreased appetite—Naltrexone—alcohol dependence	0.000397	0.00137	CcSEcCtD
Dasatinib—Gastrointestinal pain—Acamprosate—alcohol dependence	0.000394	0.00136	CcSEcCtD
Dasatinib—Gastrointestinal disorder—Naltrexone—alcohol dependence	0.000394	0.00136	CcSEcCtD
Dasatinib—Fatigue—Naltrexone—alcohol dependence	0.000393	0.00136	CcSEcCtD
Dasatinib—Visual impairment—Citalopram—alcohol dependence	0.000392	0.00136	CcSEcCtD
Dasatinib—Pain—Naltrexone—alcohol dependence	0.00039	0.00135	CcSEcCtD
Dasatinib—Constipation—Naltrexone—alcohol dependence	0.00039	0.00135	CcSEcCtD
Dasatinib—MAP3K3—midbrain—alcohol dependence	0.000389	0.00155	CbGeAlD
Dasatinib—MAP4K5—midbrain—alcohol dependence	0.000389	0.00155	CbGeAlD
Dasatinib—SIK1—nervous system—alcohol dependence	0.000386	0.00153	CbGeAlD
Dasatinib—PDGFRB—adrenal cortex—alcohol dependence	0.000386	0.00153	CbGeAlD
Dasatinib—ERBB3—testis—alcohol dependence	0.000386	0.00153	CbGeAlD
Dasatinib—MAP3K19—brain—alcohol dependence	0.000386	0.00153	CbGeAlD
Dasatinib—BMPR1B—brain—alcohol dependence	0.000386	0.00153	CbGeAlD
Dasatinib—ABL1—brainstem—alcohol dependence	0.000385	0.00153	CbGeAlD
Dasatinib—Erythema multiforme—Citalopram—alcohol dependence	0.000385	0.00133	CcSEcCtD
Dasatinib—BTK—brain—alcohol dependence	0.000384	0.00152	CbGeAlD
Dasatinib—Urticaria—Acamprosate—alcohol dependence	0.000383	0.00133	CcSEcCtD
Dasatinib—EPHA4—nervous system—alcohol dependence	0.000382	0.00152	CbGeAlD
Dasatinib—MAP3K2—testis—alcohol dependence	0.000382	0.00152	CbGeAlD
Dasatinib—YES1—digestive system—alcohol dependence	0.000382	0.00152	CbGeAlD
Dasatinib—Body temperature increased—Acamprosate—alcohol dependence	0.000381	0.00132	CcSEcCtD
Dasatinib—Abdominal pain—Acamprosate—alcohol dependence	0.000381	0.00132	CcSEcCtD
Dasatinib—RIPK2—liver—alcohol dependence	0.000381	0.00151	CbGeAlD
Dasatinib—Eye disorder—Citalopram—alcohol dependence	0.00038	0.00132	CcSEcCtD
Dasatinib—Tinnitus—Citalopram—alcohol dependence	0.000379	0.00131	CcSEcCtD
Dasatinib—ERBB3—nervous system—alcohol dependence	0.000379	0.0015	CbGeAlD
Dasatinib—TNK2—brain—alcohol dependence	0.000378	0.0015	CbGeAlD
Dasatinib—Cardiac disorder—Citalopram—alcohol dependence	0.000378	0.00131	CcSEcCtD
Dasatinib—Flushing—Citalopram—alcohol dependence	0.000378	0.00131	CcSEcCtD
Dasatinib—MAPK14—endocrine gland—alcohol dependence	0.000377	0.0015	CbGeAlD
Dasatinib—EPHB6—blood—alcohol dependence	0.000376	0.0015	CbGeAlD
Dasatinib—Feeling abnormal—Naltrexone—alcohol dependence	0.000376	0.0013	CcSEcCtD
Dasatinib—FGR—endocrine gland—alcohol dependence	0.000375	0.00149	CbGeAlD
Dasatinib—MAP3K2—nervous system—alcohol dependence	0.000375	0.00149	CbGeAlD
Dasatinib—PDGFRA—digestive system—alcohol dependence	0.000375	0.00149	CbGeAlD
Dasatinib—Gastrointestinal pain—Naltrexone—alcohol dependence	0.000373	0.00129	CcSEcCtD
Dasatinib—RIPK2—cerebellum—alcohol dependence	0.000372	0.00148	CbGeAlD
Dasatinib—SIK1—liver—alcohol dependence	0.000372	0.00148	CbGeAlD
Dasatinib—SIK1—central nervous system—alcohol dependence	0.000372	0.00148	CbGeAlD
Dasatinib—EPHB6—midbrain—alcohol dependence	0.000372	0.00148	CbGeAlD
Dasatinib—Angiopathy—Citalopram—alcohol dependence	0.000369	0.00128	CcSEcCtD
Dasatinib—EPHA4—central nervous system—alcohol dependence	0.000368	0.00146	CbGeAlD
Dasatinib—Immune system disorder—Citalopram—alcohol dependence	0.000367	0.00127	CcSEcCtD
Dasatinib—SRC—digestive system—alcohol dependence	0.000367	0.00146	CbGeAlD
Dasatinib—Mediastinal disorder—Citalopram—alcohol dependence	0.000367	0.00127	CcSEcCtD
Dasatinib—Chills—Citalopram—alcohol dependence	0.000365	0.00126	CcSEcCtD
Dasatinib—ERBB3—liver—alcohol dependence	0.000365	0.00145	CbGeAlD
Dasatinib—ERBB3—central nervous system—alcohol dependence	0.000364	0.00145	CbGeAlD
Dasatinib—YES1—blood—alcohol dependence	0.000364	0.00145	CbGeAlD
Dasatinib—SIK1—cerebellum—alcohol dependence	0.000363	0.00144	CbGeAlD
Dasatinib—Arrhythmia—Citalopram—alcohol dependence	0.000363	0.00126	CcSEcCtD
Dasatinib—Urticaria—Naltrexone—alcohol dependence	0.000362	0.00125	CcSEcCtD
Dasatinib—FMO3—endocrine gland—alcohol dependence	0.000362	0.00144	CbGeAlD
Dasatinib—MAP3K2—liver—alcohol dependence	0.000361	0.00143	CbGeAlD
Dasatinib—MAP3K2—central nervous system—alcohol dependence	0.000361	0.00143	CbGeAlD
Dasatinib—KIT—cardiovascular system—alcohol dependence	0.000361	0.00143	CbGeAlD
Dasatinib—CSF1R—gonad—alcohol dependence	0.000361	0.00143	CbGeAlD
Dasatinib—Abdominal pain—Naltrexone—alcohol dependence	0.000361	0.00125	CcSEcCtD
Dasatinib—Body temperature increased—Naltrexone—alcohol dependence	0.000361	0.00125	CcSEcCtD
Dasatinib—EPHA4—cerebellum—alcohol dependence	0.00036	0.00143	CbGeAlD
Dasatinib—Alopecia—Citalopram—alcohol dependence	0.000359	0.00124	CcSEcCtD
Dasatinib—YES1—midbrain—alcohol dependence	0.000359	0.00143	CbGeAlD
Dasatinib—MAPK14—testis—alcohol dependence	0.000359	0.00143	CbGeAlD
Dasatinib—LCK—testis—alcohol dependence	0.000358	0.00142	CbGeAlD
Dasatinib—FGR—testis—alcohol dependence	0.000358	0.00142	CbGeAlD
Dasatinib—EPHB4—endocrine gland—alcohol dependence	0.000357	0.00142	CbGeAlD
Dasatinib—PDGFRA—blood—alcohol dependence	0.000357	0.00142	CbGeAlD
Dasatinib—Mental disorder—Citalopram—alcohol dependence	0.000356	0.00123	CcSEcCtD
Dasatinib—ERBB3—cerebellum—alcohol dependence	0.000356	0.00142	CbGeAlD
Dasatinib—TESK1—brain—alcohol dependence	0.000356	0.00141	CbGeAlD
Dasatinib—Hypersensitivity—Acamprosate—alcohol dependence	0.000355	0.00123	CcSEcCtD
Dasatinib—JAK2—endocrine gland—alcohol dependence	0.000355	0.00141	CbGeAlD
Dasatinib—Malnutrition—Citalopram—alcohol dependence	0.000354	0.00123	CcSEcCtD
Dasatinib—Erythema—Citalopram—alcohol dependence	0.000354	0.00123	CcSEcCtD
Dasatinib—MAP3K2—cerebellum—alcohol dependence	0.000353	0.0014	CbGeAlD
Dasatinib—MAPK14—nervous system—alcohol dependence	0.000352	0.0014	CbGeAlD
Dasatinib—PDGFRB—cardiovascular system—alcohol dependence	0.000352	0.0014	CbGeAlD
Dasatinib—FGR—nervous system—alcohol dependence	0.000351	0.00139	CbGeAlD
Dasatinib—KIT—pancreas—alcohol dependence	0.000351	0.00139	CbGeAlD
Dasatinib—EPHA2—endocrine gland—alcohol dependence	0.00035	0.00139	CbGeAlD
Dasatinib—SRC—blood—alcohol dependence	0.00035	0.00139	CbGeAlD
Dasatinib—STK36—brain—alcohol dependence	0.00035	0.00139	CbGeAlD
Dasatinib—EPHB3—brain—alcohol dependence	0.00035	0.00139	CbGeAlD
Dasatinib—FYN—endocrine gland—alcohol dependence	0.00035	0.00139	CbGeAlD
Dasatinib—Dysgeusia—Citalopram—alcohol dependence	0.000347	0.0012	CcSEcCtD
Dasatinib—Asthenia—Acamprosate—alcohol dependence	0.000346	0.0012	CcSEcCtD
Dasatinib—FMO3—testis—alcohol dependence	0.000345	0.00137	CbGeAlD
Dasatinib—ABL1—adrenal cortex—alcohol dependence	0.000344	0.00137	CbGeAlD
Dasatinib—PDGFRB—pancreas—alcohol dependence	0.000343	0.00136	CbGeAlD
Dasatinib—MAP4K5—endocrine gland—alcohol dependence	0.000342	0.00136	CbGeAlD
Dasatinib—MAP3K3—endocrine gland—alcohol dependence	0.000342	0.00136	CbGeAlD
Dasatinib—Pruritus—Acamprosate—alcohol dependence	0.000341	0.00118	CcSEcCtD
Dasatinib—EPHB4—testis—alcohol dependence	0.00034	0.00135	CbGeAlD
Dasatinib—Muscle spasms—Citalopram—alcohol dependence	0.00034	0.00118	CcSEcCtD
Dasatinib—MAPK14—liver—alcohol dependence	0.00034	0.00135	CbGeAlD
Dasatinib—MAPK14—central nervous system—alcohol dependence	0.000339	0.00135	CbGeAlD
Dasatinib—FMO3—nervous system—alcohol dependence	0.000339	0.00135	CbGeAlD
Dasatinib—LIMK2—brain—alcohol dependence	0.000338	0.00134	CbGeAlD
Dasatinib—FGR—liver—alcohol dependence	0.000338	0.00134	CbGeAlD
Dasatinib—LCK—liver—alcohol dependence	0.000338	0.00134	CbGeAlD
Dasatinib—JAK2—testis—alcohol dependence	0.000338	0.00134	CbGeAlD
Dasatinib—FGR—central nervous system—alcohol dependence	0.000338	0.00134	CbGeAlD
Dasatinib—Hypersensitivity—Naltrexone—alcohol dependence	0.000336	0.00116	CcSEcCtD
Dasatinib—EPHA2—testis—alcohol dependence	0.000334	0.00133	CbGeAlD
Dasatinib—Vision blurred—Citalopram—alcohol dependence	0.000334	0.00115	CcSEcCtD
Dasatinib—FYN—testis—alcohol dependence	0.000333	0.00132	CbGeAlD
Dasatinib—JAK2—nervous system—alcohol dependence	0.000332	0.00132	CbGeAlD
Dasatinib—Tremor—Citalopram—alcohol dependence	0.000332	0.00115	CcSEcCtD
Dasatinib—MAPK14—cerebellum—alcohol dependence	0.000332	0.00132	CbGeAlD
Dasatinib—Diarrhoea—Acamprosate—alcohol dependence	0.00033	0.00114	CcSEcCtD
Dasatinib—CSF1R—digestive system—alcohol dependence	0.00033	0.00131	CbGeAlD
Dasatinib—Ill-defined disorder—Citalopram—alcohol dependence	0.000329	0.00114	CcSEcCtD
Dasatinib—STK35—brain—alcohol dependence	0.000328	0.0013	CbGeAlD
Dasatinib—EPHA2—nervous system—alcohol dependence	0.000328	0.0013	CbGeAlD
Dasatinib—KIT—gonad—alcohol dependence	0.000327	0.0013	CbGeAlD
Dasatinib—Anaemia—Citalopram—alcohol dependence	0.000327	0.00113	CcSEcCtD
Dasatinib—Asthenia—Naltrexone—alcohol dependence	0.000327	0.00113	CcSEcCtD
Dasatinib—FYN—nervous system—alcohol dependence	0.000327	0.0013	CbGeAlD
Dasatinib—FMO3—liver—alcohol dependence	0.000327	0.0013	CbGeAlD
Dasatinib—FMO3—central nervous system—alcohol dependence	0.000326	0.0013	CbGeAlD
Dasatinib—MAP4K5—testis—alcohol dependence	0.000326	0.00129	CbGeAlD
Dasatinib—MAP3K3—testis—alcohol dependence	0.000326	0.00129	CbGeAlD
Dasatinib—CSK—brain—alcohol dependence	0.000326	0.00129	CbGeAlD
Dasatinib—Pruritus—Naltrexone—alcohol dependence	0.000323	0.00112	CcSEcCtD
Dasatinib—MAP2K5—blood—alcohol dependence	0.000322	0.00128	CbGeAlD
Dasatinib—EPHB4—liver—alcohol dependence	0.000322	0.00128	CbGeAlD
Dasatinib—HCK—brain—alcohol dependence	0.000322	0.00128	CbGeAlD
Dasatinib—PDGFRB—gonad—alcohol dependence	0.00032	0.00127	CbGeAlD
Dasatinib—MAP3K3—nervous system—alcohol dependence	0.00032	0.00127	CbGeAlD
Dasatinib—MAP4K5—nervous system—alcohol dependence	0.00032	0.00127	CbGeAlD
Dasatinib—JAK2—liver—alcohol dependence	0.00032	0.00127	CbGeAlD
Dasatinib—ABL2—brain—alcohol dependence	0.000319	0.00127	CbGeAlD
Dasatinib—JAK2—central nervous system—alcohol dependence	0.000319	0.00127	CbGeAlD
Dasatinib—Malaise—Citalopram—alcohol dependence	0.000319	0.0011	CcSEcCtD
Dasatinib—Dizziness—Acamprosate—alcohol dependence	0.000319	0.0011	CcSEcCtD
Dasatinib—Vertigo—Citalopram—alcohol dependence	0.000318	0.0011	CcSEcCtD
Dasatinib—MAP2K5—midbrain—alcohol dependence	0.000318	0.00126	CbGeAlD
Dasatinib—Syncope—Citalopram—alcohol dependence	0.000318	0.0011	CcSEcCtD
Dasatinib—EPHA2—liver—alcohol dependence	0.000316	0.00125	CbGeAlD
Dasatinib—EPHA2—central nervous system—alcohol dependence	0.000316	0.00125	CbGeAlD
Dasatinib—YES1—endocrine gland—alcohol dependence	0.000316	0.00125	CbGeAlD
Dasatinib—FYN—liver—alcohol dependence	0.000315	0.00125	CbGeAlD
Dasatinib—FYN—central nervous system—alcohol dependence	0.000315	0.00125	CbGeAlD
Dasatinib—EPHB4—cerebellum—alcohol dependence	0.000314	0.00125	CbGeAlD
Dasatinib—CSF1R—blood—alcohol dependence	0.000314	0.00125	CbGeAlD
Dasatinib—ABL1—cardiovascular system—alcohol dependence	0.000314	0.00125	CbGeAlD
Dasatinib—Palpitations—Citalopram—alcohol dependence	0.000313	0.00108	CcSEcCtD
Dasatinib—JAK2—cerebellum—alcohol dependence	0.000312	0.00124	CbGeAlD
Dasatinib—Diarrhoea—Naltrexone—alcohol dependence	0.000312	0.00108	CcSEcCtD
Dasatinib—EPHB6—testis—alcohol dependence	0.000311	0.00124	CbGeAlD
Dasatinib—Loss of consciousness—Citalopram—alcohol dependence	0.000311	0.00108	CcSEcCtD
Dasatinib—CSF1R—midbrain—alcohol dependence	0.00031	0.00123	CbGeAlD
Dasatinib—PDGFRA—endocrine gland—alcohol dependence	0.00031	0.00123	CbGeAlD
Dasatinib—Cough—Citalopram—alcohol dependence	0.000309	0.00107	CcSEcCtD
Dasatinib—MAP4K5—liver—alcohol dependence	0.000308	0.00122	CbGeAlD
Dasatinib—MAP3K3—liver—alcohol dependence	0.000308	0.00122	CbGeAlD
Dasatinib—FYN—cerebellum—alcohol dependence	0.000308	0.00122	CbGeAlD
Dasatinib—MAP3K3—central nervous system—alcohol dependence	0.000308	0.00122	CbGeAlD
Dasatinib—MAP4K5—central nervous system—alcohol dependence	0.000308	0.00122	CbGeAlD
Dasatinib—Convulsion—Citalopram—alcohol dependence	0.000307	0.00106	CcSEcCtD
Dasatinib—Vomiting—Acamprosate—alcohol dependence	0.000307	0.00106	CcSEcCtD
Dasatinib—Hypertension—Citalopram—alcohol dependence	0.000306	0.00106	CcSEcCtD
Dasatinib—EPHB6—nervous system—alcohol dependence	0.000306	0.00121	CbGeAlD
Dasatinib—ABL1—pancreas—alcohol dependence	0.000305	0.00121	CbGeAlD
Dasatinib—Rash—Acamprosate—alcohol dependence	0.000304	0.00105	CcSEcCtD
Dasatinib—Dermatitis—Acamprosate—alcohol dependence	0.000304	0.00105	CcSEcCtD
Dasatinib—SRC—endocrine gland—alcohol dependence	0.000304	0.00121	CbGeAlD
Dasatinib—RIPK2—brain—alcohol dependence	0.000302	0.0012	CbGeAlD
Dasatinib—Headache—Acamprosate—alcohol dependence	0.000302	0.00104	CcSEcCtD
Dasatinib—Dizziness—Naltrexone—alcohol dependence	0.000302	0.00104	CcSEcCtD
Dasatinib—Chest pain—Citalopram—alcohol dependence	0.000301	0.00104	CcSEcCtD
Dasatinib—Arthralgia—Citalopram—alcohol dependence	0.000301	0.00104	CcSEcCtD
Dasatinib—Myalgia—Citalopram—alcohol dependence	0.000301	0.00104	CcSEcCtD
Dasatinib—MAP3K3—cerebellum—alcohol dependence	0.000301	0.0012	CbGeAlD
Dasatinib—MAP4K5—cerebellum—alcohol dependence	0.000301	0.0012	CbGeAlD
Dasatinib—YES1—testis—alcohol dependence	0.000301	0.0012	CbGeAlD
Dasatinib—Anxiety—Citalopram—alcohol dependence	0.0003	0.00104	CcSEcCtD
Dasatinib—KIT—digestive system—alcohol dependence	0.000299	0.00119	CbGeAlD
Dasatinib—Unspecified disorder of skin and subcutaneous tissue—Citalopram—alcohol dependence	0.000299	0.00104	CcSEcCtD
Dasatinib—Discomfort—Citalopram—alcohol dependence	0.000298	0.00103	CcSEcCtD
Dasatinib—YES1—nervous system—alcohol dependence	0.000295	0.00117	CbGeAlD
Dasatinib—PDGFRA—testis—alcohol dependence	0.000295	0.00117	CbGeAlD
Dasatinib—SIK1—brain—alcohol dependence	0.000295	0.00117	CbGeAlD
Dasatinib—EPHB6—central nervous system—alcohol dependence	0.000294	0.00117	CbGeAlD
Dasatinib—PDGFRB—digestive system—alcohol dependence	0.000293	0.00116	CbGeAlD
Dasatinib—EPHA4—brain—alcohol dependence	0.000292	0.00116	CbGeAlD
Dasatinib—Confusional state—Citalopram—alcohol dependence	0.000291	0.00101	CcSEcCtD
Dasatinib—Vomiting—Naltrexone—alcohol dependence	0.00029	0.001	CcSEcCtD
Dasatinib—PDGFRA—nervous system—alcohol dependence	0.00029	0.00115	CbGeAlD
Dasatinib—SRC—testis—alcohol dependence	0.00029	0.00115	CbGeAlD
Dasatinib—ERBB3—brain—alcohol dependence	0.000289	0.00115	CbGeAlD
Dasatinib—Oedema—Citalopram—alcohol dependence	0.000289	0.001	CcSEcCtD
Dasatinib—Rash—Naltrexone—alcohol dependence	0.000288	0.000995	CcSEcCtD
Dasatinib—EPHB6—cerebellum—alcohol dependence	0.000288	0.00114	CbGeAlD
Dasatinib—Dermatitis—Naltrexone—alcohol dependence	0.000287	0.000994	CcSEcCtD
Dasatinib—Infection—Citalopram—alcohol dependence	0.000287	0.000993	CcSEcCtD
Dasatinib—MAP3K2—brain—alcohol dependence	0.000287	0.00114	CbGeAlD
Dasatinib—Nausea—Acamprosate—alcohol dependence	0.000286	0.000991	CcSEcCtD
Dasatinib—Headache—Naltrexone—alcohol dependence	0.000286	0.000989	CcSEcCtD
Dasatinib—KIT—blood—alcohol dependence	0.000285	0.00113	CbGeAlD
Dasatinib—ABL1—gonad—alcohol dependence	0.000285	0.00113	CbGeAlD
Dasatinib—YES1—liver—alcohol dependence	0.000285	0.00113	CbGeAlD
Dasatinib—YES1—central nervous system—alcohol dependence	0.000284	0.00113	CbGeAlD
Dasatinib—Shock—Citalopram—alcohol dependence	0.000284	0.000984	CcSEcCtD
Dasatinib—SRC—nervous system—alcohol dependence	0.000284	0.00113	CbGeAlD
Dasatinib—Nervous system disorder—Citalopram—alcohol dependence	0.000283	0.000981	CcSEcCtD
Dasatinib—Thrombocytopenia—Citalopram—alcohol dependence	0.000283	0.000979	CcSEcCtD
Dasatinib—Tachycardia—Citalopram—alcohol dependence	0.000282	0.000976	CcSEcCtD
Dasatinib—KIT—midbrain—alcohol dependence	0.000282	0.00112	CbGeAlD
Dasatinib—Skin disorder—Citalopram—alcohol dependence	0.000281	0.000971	CcSEcCtD
Dasatinib—Hyperhidrosis—Citalopram—alcohol dependence	0.000279	0.000967	CcSEcCtD
Dasatinib—MAP2K5—endocrine gland—alcohol dependence	0.000279	0.00111	CbGeAlD
Dasatinib—PDGFRA—liver—alcohol dependence	0.000279	0.00111	CbGeAlD
Dasatinib—PDGFRA—central nervous system—alcohol dependence	0.000279	0.00111	CbGeAlD
Dasatinib—PDGFRB—blood—alcohol dependence	0.000279	0.00111	CbGeAlD
Dasatinib—YES1—cerebellum—alcohol dependence	0.000278	0.0011	CbGeAlD
Dasatinib—Anorexia—Citalopram—alcohol dependence	0.000275	0.000953	CcSEcCtD
Dasatinib—PDGFRB—midbrain—alcohol dependence	0.000275	0.00109	CbGeAlD
Dasatinib—SRC—liver—alcohol dependence	0.000274	0.00109	CbGeAlD
Dasatinib—SRC—central nervous system—alcohol dependence	0.000274	0.00109	CbGeAlD
Dasatinib—PDGFRA—cerebellum—alcohol dependence	0.000273	0.00108	CbGeAlD
Dasatinib—CSF1R—endocrine gland—alcohol dependence	0.000273	0.00108	CbGeAlD
Dasatinib—Nausea—Naltrexone—alcohol dependence	0.000271	0.000937	CcSEcCtD
Dasatinib—Hypotension—Citalopram—alcohol dependence	0.00027	0.000934	CcSEcCtD
Dasatinib—MAPK14—brain—alcohol dependence	0.000269	0.00107	CbGeAlD
Dasatinib—FGR—brain—alcohol dependence	0.000268	0.00107	CbGeAlD
Dasatinib—SRC—cerebellum—alcohol dependence	0.000267	0.00106	CbGeAlD
Dasatinib—MAP2K5—testis—alcohol dependence	0.000266	0.00106	CbGeAlD
Dasatinib—CYP1B1—cardiovascular system—alcohol dependence	0.000266	0.00106	CbGeAlD
Dasatinib—Musculoskeletal discomfort—Citalopram—alcohol dependence	0.000263	0.000911	CcSEcCtD
Dasatinib—Insomnia—Citalopram—alcohol dependence	0.000261	0.000904	CcSEcCtD
Dasatinib—MAP2K5—nervous system—alcohol dependence	0.000261	0.00104	CbGeAlD
Dasatinib—ABL1—digestive system—alcohol dependence	0.000261	0.00104	CbGeAlD
Dasatinib—CSF1R—testis—alcohol dependence	0.00026	0.00103	CbGeAlD
Dasatinib—FMO3—brain—alcohol dependence	0.000259	0.00103	CbGeAlD
Dasatinib—Dyspnoea—Citalopram—alcohol dependence	0.000258	0.000891	CcSEcCtD
Dasatinib—Somnolence—Citalopram—alcohol dependence	0.000257	0.000889	CcSEcCtD
Dasatinib—EPHB4—brain—alcohol dependence	0.000255	0.00101	CbGeAlD
Dasatinib—CSF1R—nervous system—alcohol dependence	0.000255	0.00101	CbGeAlD
Dasatinib—Dyspepsia—Citalopram—alcohol dependence	0.000254	0.00088	CcSEcCtD
Dasatinib—JAK2—brain—alcohol dependence	0.000254	0.00101	CbGeAlD
Dasatinib—MAP2K5—liver—alcohol dependence	0.000252	0.001	CbGeAlD
Dasatinib—MAP2K5—central nervous system—alcohol dependence	0.000252	0.001	CbGeAlD
Dasatinib—Decreased appetite—Citalopram—alcohol dependence	0.000251	0.000869	CcSEcCtD
Dasatinib—EPHA2—brain—alcohol dependence	0.000251	0.000995	CbGeAlD
Dasatinib—FYN—brain—alcohol dependence	0.00025	0.000994	CbGeAlD
Dasatinib—Gastrointestinal disorder—Citalopram—alcohol dependence	0.00025	0.000863	CcSEcCtD
Dasatinib—Fatigue—Citalopram—alcohol dependence	0.000249	0.000862	CcSEcCtD
Dasatinib—ABL1—blood—alcohol dependence	0.000248	0.000987	CbGeAlD
Dasatinib—KIT—endocrine gland—alcohol dependence	0.000247	0.000983	CbGeAlD
Dasatinib—Pain—Citalopram—alcohol dependence	0.000247	0.000855	CcSEcCtD
Dasatinib—Constipation—Citalopram—alcohol dependence	0.000247	0.000855	CcSEcCtD
Dasatinib—MAP2K5—cerebellum—alcohol dependence	0.000246	0.000977	CbGeAlD
Dasatinib—CSF1R—liver—alcohol dependence	0.000246	0.000976	CbGeAlD
Dasatinib—CSF1R—central nervous system—alcohol dependence	0.000246	0.000976	CbGeAlD
Dasatinib—ABL1—midbrain—alcohol dependence	0.000245	0.000974	CbGeAlD
Dasatinib—MAP3K3—brain—alcohol dependence	0.000244	0.000971	CbGeAlD
Dasatinib—MAP4K5—brain—alcohol dependence	0.000244	0.000971	CbGeAlD
Dasatinib—PDGFRB—endocrine gland—alcohol dependence	0.000242	0.00096	CbGeAlD
Dasatinib—CYP1B1—gonad—alcohol dependence	0.000241	0.000959	CbGeAlD
Dasatinib—CSF1R—cerebellum—alcohol dependence	0.00024	0.000954	CbGeAlD
Dasatinib—Feeling abnormal—Citalopram—alcohol dependence	0.000238	0.000824	CcSEcCtD
Dasatinib—Gastrointestinal pain—Citalopram—alcohol dependence	0.000236	0.000818	CcSEcCtD
Dasatinib—KIT—testis—alcohol dependence	0.000236	0.000938	CbGeAlD
Dasatinib—EPHB6—brain—alcohol dependence	0.000234	0.000928	CbGeAlD
Dasatinib—KIT—nervous system—alcohol dependence	0.000232	0.00092	CbGeAlD
Dasatinib—PDGFRB—testis—alcohol dependence	0.000231	0.000916	CbGeAlD
Dasatinib—Urticaria—Citalopram—alcohol dependence	0.00023	0.000794	CcSEcCtD
Dasatinib—Abdominal pain—Citalopram—alcohol dependence	0.000228	0.00079	CcSEcCtD
Dasatinib—Body temperature increased—Citalopram—alcohol dependence	0.000228	0.00079	CcSEcCtD
Dasatinib—PDGFRB—nervous system—alcohol dependence	0.000226	0.000899	CbGeAlD
Dasatinib—YES1—brain—alcohol dependence	0.000226	0.000897	CbGeAlD
Dasatinib—KIT—liver—alcohol dependence	0.000223	0.000886	CbGeAlD
Dasatinib—KIT—central nervous system—alcohol dependence	0.000223	0.000886	CbGeAlD
Dasatinib—PDGFRA—brain—alcohol dependence	0.000221	0.00088	CbGeAlD
Dasatinib—CYP1B1—digestive system—alcohol dependence	0.000221	0.000877	CbGeAlD
Dasatinib—KIT—cerebellum—alcohol dependence	0.000218	0.000866	CbGeAlD
Dasatinib—PDGFRB—liver—alcohol dependence	0.000218	0.000866	CbGeAlD
Dasatinib—PDGFRB—central nervous system—alcohol dependence	0.000218	0.000865	CbGeAlD
Dasatinib—SRC—brain—alcohol dependence	0.000217	0.000863	CbGeAlD
Dasatinib—ABCG2—adrenal cortex—alcohol dependence	0.000217	0.000862	CbGeAlD
Dasatinib—ABL1—endocrine gland—alcohol dependence	0.000215	0.000856	CbGeAlD
Dasatinib—Hypersensitivity—Citalopram—alcohol dependence	0.000213	0.000737	CcSEcCtD
Dasatinib—PDGFRB—cerebellum—alcohol dependence	0.000213	0.000846	CbGeAlD
Dasatinib—CYP1B1—blood—alcohol dependence	0.00021	0.000836	CbGeAlD
Dasatinib—Asthenia—Citalopram—alcohol dependence	0.000207	0.000717	CcSEcCtD
Dasatinib—ABL1—testis—alcohol dependence	0.000205	0.000816	CbGeAlD
Dasatinib—Pruritus—Citalopram—alcohol dependence	0.000204	0.000707	CcSEcCtD
Dasatinib—ABL1—nervous system—alcohol dependence	0.000202	0.000801	CbGeAlD
Dasatinib—MAP2K5—brain—alcohol dependence	0.0002	0.000794	CbGeAlD
Dasatinib—Diarrhoea—Citalopram—alcohol dependence	0.000198	0.000684	CcSEcCtD
Dasatinib—CSF1R—brain—alcohol dependence	0.000195	0.000775	CbGeAlD
Dasatinib—ABL1—liver—alcohol dependence	0.000194	0.000772	CbGeAlD
Dasatinib—ABL1—central nervous system—alcohol dependence	0.000194	0.000771	CbGeAlD
Dasatinib—Dizziness—Citalopram—alcohol dependence	0.000191	0.000661	CcSEcCtD
Dasatinib—ABL1—cerebellum—alcohol dependence	0.00019	0.000754	CbGeAlD
Dasatinib—Vomiting—Citalopram—alcohol dependence	0.000184	0.000636	CcSEcCtD
Dasatinib—CYP1B1—endocrine gland—alcohol dependence	0.000182	0.000725	CbGeAlD
Dasatinib—Rash—Citalopram—alcohol dependence	0.000182	0.00063	CcSEcCtD
Dasatinib—Dermatitis—Citalopram—alcohol dependence	0.000182	0.00063	CcSEcCtD
Dasatinib—Headache—Citalopram—alcohol dependence	0.000181	0.000626	CcSEcCtD
Dasatinib—CYP3A5—pancreas—alcohol dependence	0.000179	0.00071	CbGeAlD
Dasatinib—KIT—brain—alcohol dependence	0.000177	0.000703	CbGeAlD
Dasatinib—CYP1B1—testis—alcohol dependence	0.000174	0.000691	CbGeAlD
Dasatinib—PDGFRB—brain—alcohol dependence	0.000173	0.000687	CbGeAlD
Dasatinib—Nausea—Citalopram—alcohol dependence	0.000172	0.000594	CcSEcCtD
Dasatinib—CYP1B1—nervous system—alcohol dependence	0.000171	0.000678	CbGeAlD
Dasatinib—CYP1B1—liver—alcohol dependence	0.000164	0.000653	CbGeAlD
Dasatinib—CYP1B1—central nervous system—alcohol dependence	0.000164	0.000653	CbGeAlD
Dasatinib—CYP1B1—cerebellum—alcohol dependence	0.000161	0.000638	CbGeAlD
Dasatinib—CYP1A2—digestive system—alcohol dependence	0.000158	0.000629	CbGeAlD
Dasatinib—ABCG2—blood—alcohol dependence	0.000157	0.000622	CbGeAlD
Dasatinib—CYP1A1—digestive system—alcohol dependence	0.000156	0.00062	CbGeAlD
Dasatinib—ABCG2—midbrain—alcohol dependence	0.000155	0.000614	CbGeAlD
Dasatinib—ABL1—brain—alcohol dependence	0.000154	0.000612	CbGeAlD
Dasatinib—CYP3A5—digestive system—alcohol dependence	0.000153	0.000606	CbGeAlD
Dasatinib—CYP1A2—blood—alcohol dependence	0.000151	0.000599	CbGeAlD
Dasatinib—CYP1A1—blood—alcohol dependence	0.000149	0.000591	CbGeAlD
Dasatinib—CYP3A5—blood—alcohol dependence	0.000145	0.000578	CbGeAlD
Dasatinib—CYP1A2—endocrine gland—alcohol dependence	0.000131	0.000519	CbGeAlD
Dasatinib—CYP1B1—brain—alcohol dependence	0.000131	0.000519	CbGeAlD
Dasatinib—ABCG2—testis—alcohol dependence	0.00013	0.000515	CbGeAlD
Dasatinib—CYP1A1—endocrine gland—alcohol dependence	0.000129	0.000512	CbGeAlD
Dasatinib—CYP3A5—endocrine gland—alcohol dependence	0.000126	0.000501	CbGeAlD
Dasatinib—ABCG2—liver—alcohol dependence	0.000122	0.000487	CbGeAlD
Dasatinib—CYP1A1—nervous system—alcohol dependence	0.000121	0.00048	CbGeAlD
Dasatinib—ABCG2—cerebellum—alcohol dependence	0.00012	0.000475	CbGeAlD
Dasatinib—CYP1A2—liver—alcohol dependence	0.000118	0.000468	CbGeAlD
Dasatinib—CYP1A1—liver—alcohol dependence	0.000116	0.000462	CbGeAlD
Dasatinib—CYP1A1—central nervous system—alcohol dependence	0.000116	0.000462	CbGeAlD
Dasatinib—ABCB1—forebrain—alcohol dependence	0.000116	0.000459	CbGeAlD
Dasatinib—CYP3A4—digestive system—alcohol dependence	0.000115	0.000455	CbGeAlD
Dasatinib—CYP3A5—liver—alcohol dependence	0.000114	0.000452	CbGeAlD
Dasatinib—CYP3A4—blood—alcohol dependence	0.000109	0.000433	CbGeAlD
Dasatinib—ABCB1—adrenal cortex—alcohol dependence	0.000107	0.000425	CbGeAlD
Dasatinib—ABCB1—cardiovascular system—alcohol dependence	9.77e-05	0.000388	CbGeAlD
Dasatinib—ABCG2—brain—alcohol dependence	9.72e-05	0.000386	CbGeAlD
Dasatinib—ABCB1—pancreas—alcohol dependence	9.49e-05	0.000377	CbGeAlD
Dasatinib—CYP3A4—endocrine gland—alcohol dependence	9.46e-05	0.000376	CbGeAlD
Dasatinib—CYP1A1—brain—alcohol dependence	9.23e-05	0.000367	CbGeAlD
Dasatinib—ABCB1—gonad—alcohol dependence	8.86e-05	0.000352	CbGeAlD
Dasatinib—CYP3A4—nervous system—alcohol dependence	8.86e-05	0.000352	CbGeAlD
Dasatinib—CYP3A4—liver—alcohol dependence	8.53e-05	0.000339	CbGeAlD
Dasatinib—CYP3A4—central nervous system—alcohol dependence	8.53e-05	0.000339	CbGeAlD
Dasatinib—ABCB1—digestive system—alcohol dependence	8.11e-05	0.000322	CbGeAlD
Dasatinib—ABCB1—blood—alcohol dependence	7.72e-05	0.000307	CbGeAlD
Dasatinib—ABCB1—midbrain—alcohol dependence	7.63e-05	0.000303	CbGeAlD
Dasatinib—ABCB1—endocrine gland—alcohol dependence	6.7e-05	0.000266	CbGeAlD
Dasatinib—ABCB1—testis—alcohol dependence	6.39e-05	0.000254	CbGeAlD
Dasatinib—ABCB1—nervous system—alcohol dependence	6.27e-05	0.000249	CbGeAlD
Dasatinib—ABCB1—liver—alcohol dependence	6.04e-05	0.00024	CbGeAlD
Dasatinib—ABCB1—central nervous system—alcohol dependence	6.04e-05	0.00024	CbGeAlD
Dasatinib—ABCB1—cerebellum—alcohol dependence	5.9e-05	0.000234	CbGeAlD
Dasatinib—ABCB1—brain—alcohol dependence	4.79e-05	0.00019	CbGeAlD
Dasatinib—LYN—Signaling Pathways—HTR1B—alcohol dependence	2.08e-05	0.000109	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—CRH—alcohol dependence	2.08e-05	0.000109	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—CNR1—alcohol dependence	2.08e-05	0.000108	CbGpPWpGaD
Dasatinib—JAK2—GPCR downstream signaling—HTR2A—alcohol dependence	2.07e-05	0.000108	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—DRD4—alcohol dependence	2.06e-05	0.000108	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—HTR2A—alcohol dependence	2.05e-05	0.000107	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—HTR1B—alcohol dependence	2.05e-05	0.000107	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—CRH—alcohol dependence	2.05e-05	0.000107	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—NPY—alcohol dependence	2.04e-05	0.000107	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—ADH1A—alcohol dependence	2.03e-05	0.000106	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—DRD2—alcohol dependence	2.03e-05	0.000106	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—HTR7—alcohol dependence	2.03e-05	0.000106	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—ADH1B—alcohol dependence	2.02e-05	0.000105	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—NPY—alcohol dependence	2.02e-05	0.000105	CbGpPWpGaD
Dasatinib—MAP3K3—Immune System—EP300—alcohol dependence	2e-05	0.000105	CbGpPWpGaD
Dasatinib—KIT—Innate Immune System—EP300—alcohol dependence	2e-05	0.000104	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—HTR1B—alcohol dependence	1.97e-05	0.000103	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—CRH—alcohol dependence	1.97e-05	0.000103	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—WASF2—alcohol dependence	1.97e-05	0.000103	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—CRHR1—alcohol dependence	1.97e-05	0.000103	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—CNR1—alcohol dependence	1.97e-05	0.000103	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism—GOT2—alcohol dependence	1.96e-05	0.000102	CbGpPWpGaD
Dasatinib—SRC—Disease—GOT2—alcohol dependence	1.95e-05	0.000102	CbGpPWpGaD
Dasatinib—BTK—Immune System—EP300—alcohol dependence	1.95e-05	0.000102	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—HTR1B—alcohol dependence	1.95e-05	0.000102	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—CRH—alcohol dependence	1.95e-05	0.000102	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—OPRM1—alcohol dependence	1.92e-05	0.0001	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—HTR7—alcohol dependence	1.92e-05	0.0001	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—DRD2—alcohol dependence	1.92e-05	0.0001	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—AVP—alcohol dependence	1.91e-05	9.97e-05	CbGpPWpGaD
Dasatinib—LCK—Disease—GOT1—alcohol dependence	1.9e-05	9.91e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Innate Immune System—EP300—alcohol dependence	1.89e-05	9.87e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—ADH6—alcohol dependence	1.89e-05	9.86e-05	CbGpPWpGaD
Dasatinib—LYN—Developmental Biology—EP300—alcohol dependence	1.89e-05	9.86e-05	CbGpPWpGaD
Dasatinib—ABCB1—Transmembrane transport of small molecules—SLC6A3—alcohol dependence	1.89e-05	9.86e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—WASF1—alcohol dependence	1.89e-05	9.85e-05	CbGpPWpGaD
Dasatinib—ABL1—Developmental Biology—EP300—alcohol dependence	1.88e-05	9.81e-05	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—HTR2A—alcohol dependence	1.88e-05	9.81e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling by GPCR—HTR2A—alcohol dependence	1.88e-05	9.8e-05	CbGpPWpGaD
Dasatinib—FYN—Developmental Biology—EP300—alcohol dependence	1.86e-05	9.7e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—DRD4—alcohol dependence	1.86e-05	9.69e-05	CbGpPWpGaD
Dasatinib—LYN—Hemostasis—EP300—alcohol dependence	1.85e-05	9.67e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—CHRM2—alcohol dependence	1.85e-05	9.66e-05	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism—CYP2E1—alcohol dependence	1.85e-05	9.63e-05	CbGpPWpGaD
Dasatinib—ABL1—Hemostasis—EP300—alcohol dependence	1.84e-05	9.63e-05	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—ADH7—alcohol dependence	1.84e-05	9.59e-05	CbGpPWpGaD
Dasatinib—FYN—Hemostasis—EP300—alcohol dependence	1.82e-05	9.52e-05	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—DRD4—alcohol dependence	1.82e-05	9.48e-05	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—HTR2A—alcohol dependence	1.81e-05	9.45e-05	CbGpPWpGaD
Dasatinib—MAPK14—Developmental Biology—EP300—alcohol dependence	1.79e-05	9.34e-05	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—DRD4—alcohol dependence	1.79e-05	9.34e-05	CbGpPWpGaD
Dasatinib—HCK—Immune System—EP300—alcohol dependence	1.79e-05	9.33e-05	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—GOT2—alcohol dependence	1.79e-05	9.32e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—CNR1—alcohol dependence	1.77e-05	9.25e-05	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—MAOB—alcohol dependence	1.77e-05	9.23e-05	CbGpPWpGaD
Dasatinib—JAK2—Developmental Biology—EP300—alcohol dependence	1.77e-05	9.22e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—NPY—alcohol dependence	1.77e-05	9.22e-05	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—GGT2—alcohol dependence	1.76e-05	9.19e-05	CbGpPWpGaD
Dasatinib—MAPK14—Hemostasis—EP300—alcohol dependence	1.76e-05	9.17e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Biological oxidations—POMC—alcohol dependence	1.75e-05	9.14e-05	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—CNR1—alcohol dependence	1.74e-05	9.06e-05	CbGpPWpGaD
Dasatinib—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—alcohol dependence	1.73e-05	9.05e-05	CbGpPWpGaD
Dasatinib—JAK2—Hemostasis—EP300—alcohol dependence	1.73e-05	9.05e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—HTR7—alcohol dependence	1.73e-05	9.02e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—DRD2—alcohol dependence	1.73e-05	9.02e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—ADH4—alcohol dependence	1.73e-05	9e-05	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—DRD4—alcohol dependence	1.72e-05	8.99e-05	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—CNR1—alcohol dependence	1.71e-05	8.92e-05	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—AVP—alcohol dependence	1.71e-05	8.91e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—HTR1B—alcohol dependence	1.7e-05	8.89e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—CRH—alcohol dependence	1.7e-05	8.89e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Innate Immune System—EP300—alcohol dependence	1.7e-05	8.89e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—DRD4—alcohol dependence	1.7e-05	8.88e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—OPRM1—alcohol dependence	1.7e-05	8.87e-05	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism—GOT1—alcohol dependence	1.69e-05	8.84e-05	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism—GGT1—alcohol dependence	1.69e-05	8.84e-05	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—HTR7—alcohol dependence	1.69e-05	8.84e-05	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—DRD2—alcohol dependence	1.69e-05	8.84e-05	CbGpPWpGaD
Dasatinib—RIPK2—Immune System—EP300—alcohol dependence	1.68e-05	8.79e-05	CbGpPWpGaD
Dasatinib—SRC—Disease—GOT1—alcohol dependence	1.68e-05	8.78e-05	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—CYP2E1—alcohol dependence	1.68e-05	8.76e-05	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—MAOB—alcohol dependence	1.67e-05	8.72e-05	CbGpPWpGaD
Dasatinib—LYN—Innate Immune System—EP300—alcohol dependence	1.67e-05	8.71e-05	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—DRD2—alcohol dependence	1.67e-05	8.7e-05	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—HTR7—alcohol dependence	1.67e-05	8.7e-05	CbGpPWpGaD
Dasatinib—ABL1—Innate Immune System—EP300—alcohol dependence	1.66e-05	8.67e-05	CbGpPWpGaD
Dasatinib—JAK2—GPCR downstream signaling—POMC—alcohol dependence	1.65e-05	8.62e-05	CbGpPWpGaD
Dasatinib—HCK—Disease—EP300—alcohol dependence	1.65e-05	8.61e-05	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—CNR1—alcohol dependence	1.64e-05	8.58e-05	CbGpPWpGaD
Dasatinib—FYN—Innate Immune System—EP300—alcohol dependence	1.64e-05	8.57e-05	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—POMC—alcohol dependence	1.64e-05	8.56e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—CNR1—alcohol dependence	1.62e-05	8.47e-05	CbGpPWpGaD
Dasatinib—BLK—Immune System—EP300—alcohol dependence	1.62e-05	8.45e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—AVP—alcohol dependence	1.62e-05	8.43e-05	CbGpPWpGaD
Dasatinib—FGR—Immune System—EP300—alcohol dependence	1.61e-05	8.42e-05	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—ADH1B—alcohol dependence	1.61e-05	8.41e-05	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—DRD2—alcohol dependence	1.6e-05	8.38e-05	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—HTR7—alcohol dependence	1.6e-05	8.38e-05	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—HTR2A—alcohol dependence	1.59e-05	8.3e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—HTR7—alcohol dependence	1.58e-05	8.27e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—DRD2—alcohol dependence	1.58e-05	8.27e-05	CbGpPWpGaD
Dasatinib—MAPK14—Innate Immune System—EP300—alcohol dependence	1.58e-05	8.25e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—ADH1A—alcohol dependence	1.57e-05	8.17e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—NPY—alcohol dependence	1.56e-05	8.16e-05	CbGpPWpGaD
Dasatinib—ABCB1—Transmembrane transport of small molecules—AVP—alcohol dependence	1.56e-05	8.15e-05	CbGpPWpGaD
Dasatinib—JAK2—Innate Immune System—EP300—alcohol dependence	1.56e-05	8.15e-05	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—GGT1—alcohol dependence	1.54e-05	8.04e-05	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—GOT1—alcohol dependence	1.54e-05	8.04e-05	CbGpPWpGaD
Dasatinib—LCK—Hemostasis—EP300—alcohol dependence	1.52e-05	7.93e-05	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism—MAOA—alcohol dependence	1.52e-05	7.92e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—HTR1B—alcohol dependence	1.51e-05	7.87e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—CRH—alcohol dependence	1.51e-05	7.87e-05	CbGpPWpGaD
Dasatinib—CSK—Signaling Pathways—EP300—alcohol dependence	1.51e-05	7.86e-05	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—ALDH2—alcohol dependence	1.5e-05	7.85e-05	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—POMC—alcohol dependence	1.5e-05	7.83e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling by GPCR—POMC—alcohol dependence	1.5e-05	7.83e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	1.49e-05	7.8e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—DRD4—alcohol dependence	1.49e-05	7.77e-05	CbGpPWpGaD
Dasatinib—ERBB3—Immune System—EP300—alcohol dependence	1.48e-05	7.75e-05	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	1.47e-05	7.68e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—ADH7—alcohol dependence	1.47e-05	7.66e-05	CbGpPWpGaD
Dasatinib—FMO3—Metabolism—EP300—alcohol dependence	1.46e-05	7.62e-05	CbGpPWpGaD
Dasatinib—STAT5B—Signaling Pathways—EP300—alcohol dependence	1.46e-05	7.61e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—AVP—alcohol dependence	1.46e-05	7.6e-05	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—POMC—alcohol dependence	1.45e-05	7.55e-05	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—AVP—alcohol dependence	1.42e-05	7.44e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—CNR1—alcohol dependence	1.42e-05	7.42e-05	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—ALDH2—alcohol dependence	1.42e-05	7.42e-05	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—HTR2A—alcohol dependence	1.42e-05	7.41e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—GGT2—alcohol dependence	1.41e-05	7.34e-05	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—AVP—alcohol dependence	1.4e-05	7.32e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—DRD2—alcohol dependence	1.39e-05	7.24e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—HTR7—alcohol dependence	1.39e-05	7.24e-05	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—MAOA—alcohol dependence	1.38e-05	7.21e-05	CbGpPWpGaD
Dasatinib—SRC—Developmental Biology—EP300—alcohol dependence	1.37e-05	7.15e-05	CbGpPWpGaD
Dasatinib—ERBB3—Disease—EP300—alcohol dependence	1.37e-05	7.15e-05	CbGpPWpGaD
Dasatinib—LCK—Innate Immune System—EP300—alcohol dependence	1.37e-05	7.14e-05	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	1.37e-05	7.13e-05	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—AVP—alcohol dependence	1.35e-05	7.05e-05	CbGpPWpGaD
Dasatinib—SRC—Hemostasis—EP300—alcohol dependence	1.34e-05	7.02e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—HTR2A—alcohol dependence	1.34e-05	7.02e-05	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—MAOB—alcohol dependence	1.34e-05	6.97e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—AVP—alcohol dependence	1.33e-05	6.96e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—ADH4—alcohol dependence	1.33e-05	6.95e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—DRD4—alcohol dependence	1.32e-05	6.88e-05	CbGpPWpGaD
Dasatinib—YES1—Immune System—EP300—alcohol dependence	1.3e-05	6.8e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—ADH1B—alcohol dependence	1.29e-05	6.71e-05	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—GOT2—alcohol dependence	1.28e-05	6.68e-05	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—POMC—alcohol dependence	1.27e-05	6.63e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—CNR1—alcohol dependence	1.26e-05	6.57e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—DRD2—alcohol dependence	1.23e-05	6.41e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—HTR7—alcohol dependence	1.23e-05	6.41e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—HTR2A—alcohol dependence	1.21e-05	6.32e-05	CbGpPWpGaD
Dasatinib—SRC—Innate Immune System—EP300—alcohol dependence	1.21e-05	6.32e-05	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—GOT2—alcohol dependence	1.21e-05	6.31e-05	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—CYP2E1—alcohol dependence	1.2e-05	6.28e-05	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—HTR2A—alcohol dependence	1.19e-05	6.19e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—AVP—alcohol dependence	1.17e-05	6.1e-05	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—HTR2A—alcohol dependence	1.17e-05	6.09e-05	CbGpPWpGaD
Dasatinib—KIT—Immune System—EP300—alcohol dependence	1.16e-05	6.07e-05	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—CYP2E1—alcohol dependence	1.14e-05	5.93e-05	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—ALDH2—alcohol dependence	1.14e-05	5.93e-05	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—POMC—alcohol dependence	1.13e-05	5.92e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—ADH7—alcohol dependence	1.13e-05	5.91e-05	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—HTR2A—alcohol dependence	1.12e-05	5.87e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—HTR2A—alcohol dependence	1.11e-05	5.79e-05	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—GOT1—alcohol dependence	1.1e-05	5.76e-05	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—GGT1—alcohol dependence	1.1e-05	5.76e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Immune System—EP300—alcohol dependence	1.1e-05	5.75e-05	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—EP300—alcohol dependence	1.09e-05	5.68e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—GGT2—alcohol dependence	1.09e-05	5.66e-05	CbGpPWpGaD
Dasatinib—KIT—Disease—EP300—alcohol dependence	1.07e-05	5.61e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—POMC—alcohol dependence	1.07e-05	5.6e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—MAOB—alcohol dependence	1.07e-05	5.56e-05	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—GOT1—alcohol dependence	1.04e-05	5.44e-05	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—GGT1—alcohol dependence	1.04e-05	5.44e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—AVP—alcohol dependence	1.03e-05	5.4e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Disease—EP300—alcohol dependence	1.02e-05	5.31e-05	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—EP300—alcohol dependence	9.96e-06	5.2e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—ADH1B—alcohol dependence	9.93e-06	5.18e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—EP300—alcohol dependence	9.92e-06	5.18e-05	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—MAOA—alcohol dependence	9.9e-06	5.16e-05	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism—POMC—alcohol dependence	9.88e-06	5.16e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—HTR2A—alcohol dependence	9.72e-06	5.07e-05	CbGpPWpGaD
Dasatinib—LYN—Immune System—EP300—alcohol dependence	9.72e-06	5.07e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—POMC—alcohol dependence	9.67e-06	5.05e-05	CbGpPWpGaD
Dasatinib—ABL1—Immune System—EP300—alcohol dependence	9.67e-06	5.05e-05	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—GOT2—alcohol dependence	9.65e-06	5.04e-05	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—EP300—alcohol dependence	9.6e-06	5.01e-05	CbGpPWpGaD
Dasatinib—FYN—Immune System—EP300—alcohol dependence	9.57e-06	4.99e-05	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—POMC—alcohol dependence	9.47e-06	4.94e-05	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—MAOA—alcohol dependence	9.35e-06	4.88e-05	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—POMC—alcohol dependence	9.32e-06	4.87e-05	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—EP300—alcohol dependence	9.21e-06	4.81e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Disease—EP300—alcohol dependence	9.16e-06	4.78e-05	CbGpPWpGaD
Dasatinib—JAK2—Immune System—EP300—alcohol dependence	9.09e-06	4.75e-05	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—CYP2E1—alcohol dependence	9.08e-06	4.74e-05	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	9.07e-06	4.73e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—ALDH2—alcohol dependence	9.06e-06	4.73e-05	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—POMC—alcohol dependence	8.99e-06	4.69e-05	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—POMC—alcohol dependence	8.98e-06	4.68e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—POMC—alcohol dependence	8.86e-06	4.62e-05	CbGpPWpGaD
Dasatinib—FYN—Disease—EP300—alcohol dependence	8.83e-06	4.61e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	8.71e-06	4.55e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—HTR2A—alcohol dependence	8.6e-06	4.49e-05	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—EP300—alcohol dependence	8.42e-06	4.4e-05	CbGpPWpGaD
Dasatinib—JAK2—Disease—EP300—alcohol dependence	8.39e-06	4.38e-05	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—GGT1—alcohol dependence	8.33e-06	4.35e-05	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—GOT1—alcohol dependence	8.33e-06	4.35e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—MAOB—alcohol dependence	8.23e-06	4.29e-05	CbGpPWpGaD
Dasatinib—LCK—Immune System—EP300—alcohol dependence	7.96e-06	4.16e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—POMC—alcohol dependence	7.76e-06	4.05e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—GOT2—alcohol dependence	7.71e-06	4.02e-05	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—EP300—alcohol dependence	7.52e-06	3.93e-05	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—MAOA—alcohol dependence	7.47e-06	3.9e-05	CbGpPWpGaD
Dasatinib—LCK—Disease—EP300—alcohol dependence	7.35e-06	3.84e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—CYP2E1—alcohol dependence	7.25e-06	3.78e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—EP300—alcohol dependence	7.12e-06	3.72e-05	CbGpPWpGaD
Dasatinib—SRC—Immune System—EP300—alcohol dependence	7.05e-06	3.68e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—ALDH2—alcohol dependence	6.99e-06	3.65e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—POMC—alcohol dependence	6.87e-06	3.59e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—GOT1—alcohol dependence	6.65e-06	3.47e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—GGT1—alcohol dependence	6.65e-06	3.47e-05	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism—EP300—alcohol dependence	6.56e-06	3.42e-05	CbGpPWpGaD
Dasatinib—SRC—Disease—EP300—alcohol dependence	6.51e-06	3.4e-05	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—POMC—alcohol dependence	6.44e-06	3.36e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—EP300—alcohol dependence	6.42e-06	3.35e-05	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—EP300—alcohol dependence	6.28e-06	3.28e-05	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—EP300—alcohol dependence	6.18e-06	3.23e-05	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—POMC—alcohol dependence	6.09e-06	3.18e-05	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—EP300—alcohol dependence	5.97e-06	3.11e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—MAOA—alcohol dependence	5.96e-06	3.11e-05	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—EP300—alcohol dependence	5.95e-06	3.11e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—GOT2—alcohol dependence	5.95e-06	3.1e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—EP300—alcohol dependence	5.88e-06	3.07e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	5.78e-06	3.02e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—CYP2E1—alcohol dependence	5.59e-06	2.92e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—EP300—alcohol dependence	5.15e-06	2.69e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—GGT1—alcohol dependence	5.13e-06	2.68e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—GOT1—alcohol dependence	5.13e-06	2.68e-05	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—POMC—alcohol dependence	4.86e-06	2.54e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—MAOA—alcohol dependence	4.6e-06	2.4e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—EP300—alcohol dependence	4.56e-06	2.38e-05	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—EP300—alcohol dependence	4.27e-06	2.23e-05	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—EP300—alcohol dependence	4.04e-06	2.11e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—POMC—alcohol dependence	3.88e-06	2.03e-05	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—EP300—alcohol dependence	3.23e-06	1.68e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—POMC—alcohol dependence	3e-06	1.56e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—EP300—alcohol dependence	2.57e-06	1.34e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—EP300—alcohol dependence	1.99e-06	1.04e-05	CbGpPWpGaD
